糖尿病 Diabetes

全球大約有四億兩千五百萬名成年人患有糖尿病，其中第二型糖尿病佔所有病例的90%-95%。根據預測，到了2045年，這個數字預計將增加至六億二千九百萬人。第二型糖尿病是一種慢性疾病，長期的併發症包括中風、心臟病發作、心血管死亡，以及糖尿病性腎病、視網膜病變、手臂和腿的截肢，以及自主神經病變。除了我們自家研發的產品，以及我們與合作夥伴禮來公司（Eli Lilly and Company）共同推出的基礎胰島素之外，我們也專注於存在著高度未滿足醫療需求的心臟代謝疾病領域。

About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. This number is projected to increase to 629 million people by 20451. Type 2 diabetes is a chronic, progressive condition and long-term complications include stroke, heart attack and cardiovascular death as well as diabetic kidney disease, retinopathy, arm and leg amputations and autonomic neuropathy. In addition to the now marketed products from our own R&D, and basal insulin from our alliance partner Eli Lilly and Company, we are also focused on cardiometabolic indications with a high unmet medical need.